Clinical Trial Update: Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis [NA]

View source ↗

Summary

A clinical trial is evaluating intra-articular bevacizumab to prevent recurrent joint bleeding (hemarthrosis) in patients with hemophilia and chronic synovitis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia
• Synovitis

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Khyber Medical University Peshawar | Conditions: Hemophilia, Chronic Synovitis | NA | Status: RECRUITING